Summit Therapeutics Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2025: -42.19

Summit Therapeutics Inc. Interest Coverage Ratio is -42.19 for the Trailing 12 Months (TTM) ending March 31, 2025. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
  • Summit Therapeutics Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -46.69, a -23.22% change year over year.
  • Summit Therapeutics Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -60.81, a -39.41% change year over year.
  • Summit Therapeutics Inc. Interest Coverage Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was -100.37.
Key Data
Date Interest Coverage Ratio Return on Capital Employed (ROCE) Return on Equity (ROE) Return on Assets (ROA)